Reagent kit for enzyme-linked immunosorbent determination of proinsulin in genetically engineered human insulin (PancreoELISA-proinsulin)
Russia·Unknown·CJSC Alkor Bio·Registered August 23, 2005·N/A- Device Name (English)
- Reagent kit for enzyme-linked immunosorbent determination of proinsulin in genetically engineered human insulin (PancreoELISA-proinsulin)
- Device Name (Russian)
- Набор реагентов для иммуноферментоного определения проинсулина в генно-инженерном инсулине человека (ПанкреоИФА-проинсулин)
- Device Type (English)
- N/A
- Device Type (Russian)
- Unknown
- Risk Class
- N/A
- Registry Key
- o27625
- Registration Number
- ФС 01012005/2231-05
- Registration Date
- August 23, 2005
- Validity Period
- August 23, 2010
- Manufacturer Name (English)
- CJSC Alkor Bio
- Manufacturer Name (Russian)
- ЗАО Алкор Био
- Country (English)
- Russia
- Country (Russian)
- Россия
- Legal Address (English)
- Saint Petersburg
- Legal Address (Russian)
- Санкт-Петербург
Access comprehensive regulatory information for Reagent kit for enzyme-linked immunosorbent determination of proinsulin in genetically engineered human insulin (PancreoELISA-proinsulin) in the Russia medical device market through Pure Global AI's free database. This medical device is registered under Roszdravnadzor registration number ФС 01012005/2231-05 and manufactured by CJSC Alkor Bio. The device was registered on August 23, 2005.
This page provides complete registration details including device type, manufacturer information, country of origin (Russia), and regulatory compliance data from the official Russia Roszdravnadzor medical device database. Pure Global AI offers free access to Russia's complete medical device registry, helping global MedTech companies navigate Roszdravnadzor regulations efficiently.